Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome
PeerJ · 2025
DOI: 10.7717/peerj.18859 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Elif Tugba Tuncel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine Department of Gastroenterology, Celal Bayar University, Manisa, Turkey. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Diarrhea, Constipation, Intercellular Signaling Peptides and Proteins. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Inflammation and immunity play major roles in the etiopathogenesis of functional intestinal disorders. The salusins that were identified in this study are important because of their ease of collection, sensitivity and reliability. For that reason, the aim of this study was to analyze the importance of the levels of salusin in the blood, an inflammation-related parameter, in the diagnosis and prediction of irritable bowel disease. Methodology The study participants included 28 diagnosed with constipation-predominant IBS, 29 (34.1%) diagnosed with diarrhea-predominant IBS (D-IBS), and 28 (32.9%) controls. Enzyme-linked immune-sorbent assay (ELISA) method has been used for the measurement of salusin levels.
Results
Participants were 50 (58.8%) female and 35 (41.2%) male. The serum levels of salusin-α were substantially reduced in the diarrhea-predominant IBS group vs controls. There was also no major difference in the levels of salusin between the constipation-predominant-IBS and the diarrhea-predominant IBS group.
Conclusion
A major prognostic relationship was found between the level of salusins and the subgroup of D-IBS. It is well known that salusins have been related to inflammatory processes and oxidative injury in previous studies. The relationship between salusin and gastrointestinal diseases should be further investigated. Low-grade submucosal intestinal inflammation is also associated with irritable bowel syndrome. It is our belief that salusins may be useful in diagnosing, predicting or treating IBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine Department of Gastroenterology, Celal Bayar University, Manisa, Turkey.
- Department of Medical Biology School of Medicine, Celal Bayar University, Manisa, Turkey.
- Faculty of Medicine Department of Internal Medicine, Celal Bayar University, Manisa, Turkey.
Zitieren
APA
Tuncel, E. T., Ozcan, S. S., Korkmaz, M., & Börekci, E. (2025). Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome. PeerJ. https://doi.org/10.7717/peerj.18859
Vancouver
Tuncel ET, Ozcan SS, Korkmaz M, Börekci E. Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome. PeerJ. 2025. doi:10.7717/peerj.18859
BibTeX
@article{Tuncel2025,
author = {Tuncel, Elif Tugba and Ozcan, Seda Sabah and Korkmaz, Mehmet and Börekci, Elif},
title = {Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.18859}
}
EUVIMED